J3590 reimbursement. 21, 2018, the North Carolina Medicaid and NC Health Choice program...
J3590 reimbursement. 21, 2018, the North Carolina Medicaid and NC Health Choice programs cover ravulizumab-cwvz injection, for intravenous use (Ultomiris) for use in the Physician Administered Drug Program when billed with HCPCS code J3590 - Unclassified Biologics. Dec 2, 2025 · Effective for dates of service on and after June 1, 2026, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process. Read a complete guide to HCPCS J3590. . Federal and state law, as well as state contract language and CMS guidelines — including definitions and specific contract provisions/exclusions — take precedence over these precertification rules and must be Dec 2, 2025 · Effective for dates of service on and after June 1, 2026, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process. Check with payer for reimbursement and do not miss the pre-medications. Blinatunomab (Blincyto TM) is indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Federal and state law, as well as state contract language and CMS guidelines — including definitions and specific contract provisions/exclusions — take precedence over these precertification rules and must be Mar 1, 2018 · Use this page to view details for the Local Coverage Article for Billing and Coding: Hospital Outpatient Drugs and Biologicals Under the Outpatient Prospective Payment System (OPPS). This guide explains how to use it correctly to avoid denials and get paid faster. Billing Miscellaneous HCPCS codes – J3490, J3590 As mentioned, Aduhelm is a newly FDA-approved medication; so, no permanent HCPCS code has been assigned. Mar 1, 2019 · Effective with date of service Dec. Federal and state law, as well as state contract language and CMS guidelines — including definitions and specific contract provisions/exclusions — take precedence over these precertification rules and must be HCPCS Code J3590 Unclassified biologics Drugs administered other than oral method, chemotherapy drugs J3590 is a valid 2026 HCPCS code for Unclassified biologics used in Medical care. Therefore, billers must currently use a miscellaneous code, either J3490 or J3590, on Aduhelm claims. Healthcare Common Procedure Coding System J3590 is a non-specific, miscellaneous drug code used in the billing and reimbursement process for outpatient services in the United States. Learn essential billing guidelines, documentation, NDC, and JW/JZ modifiers for unclassified biologics. If you need to bill Medicare for a drug that doesn’t have a specific code, J3590 is the code you’ll likely use, but only if you understand how it works. When using a drug NOC code (J3490, or J3590) list the name of the drug, the amount of the drug that is administered and wasted if applicable; method of administration in the electronic narrative that is equivalent to line 19 of the CMS 1500 form. Review description and fee schedules for HCPCS Code J3590, intended for Drugs Administered Other than Oral Method, and compare rates across different payers. Dec 19, 2025 · Since the compounded medications do not have an NDC, specific HCPCS J-codes cannot be used. Instead, providers should bill J3490 (unclassified drugs); J3590 (unclassified biologics); J7999 (compounded drug, not Oral) or J9999 (Not Otherwise Classified (NOC), antineoplastic drug). May 9, 2025 · J3590 is used to bill Medicare for drugs without a specific code. qkrmjxjoisjbcmekkwefhhcgcmmjmwoemsqjmyokzovku